Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group. [electronic resource]
Producer: 19980918Description: 1232-9 p. digitalISSN:- 0903-1936
- Acetates -- administration & dosage
- Adolescent
- Adult
- Aged
- Asthma -- drug therapy
- Chronic Disease
- Cyclopropanes
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Forced Expiratory Volume -- drug effects
- Humans
- Leukotriene Antagonists
- Male
- Middle Aged
- Peak Expiratory Flow Rate -- drug effects
- Quality of Life
- Quinolines -- administration & dosage
- Spirometry
- Sulfides
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.